GBCS earnings analysis
What we found in GBCS's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The extracted Form 10-Q text does not include income statement, segment, balance-sheet, or cash-flow figures, so operating trends and free cash flow cannot be assessed from the available filing content. The principal disclosure is significant control weakness: disclosure controls were ineffective as of June 30, 2026, and two material weaknesses remained unremediated. A Utah-law issue also required $401,000 to be reclassified from equity to liabilities, while remediation is planned for 2026.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Management Supports Financial Statement Presentation
- Management stated that the financial statements present fairly in all material respects after performing additional analysis in response to the disclosed control weaknesses.
- Control Remediation Planned for 2026
- The Company plans to implement multi-level review in 2026 and intends to work with internal personnel and third parties to strengthen controls.
- No Further Quarterly Control Change Reported
- Management reported no change during the quarter ended June 30, 2026 that materially affected, or was reasonably likely to materially affect, internal control over financial reporting.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Ineffective Disclosure Controls
- Disclosure controls and procedures were concluded to be ineffective as of June 30, 2026, meaning they did not provide assurance that required information would be timely recorded, processed, summarized, and reported.
- Unremediated Review Weakness
- The material weakness identified during preparation of the 2025 Form 10-K, involving inadequate multi-level review and untimely account and reconciliation reviews, was not remediated as of June 30, 2026 and could permit a material misstatement.
- Preferred Stock Classification Issue
- A Utah-law technical defect involving the historical issuance of Series A Convertible Preferred Stock required $401,000 previously classified as equity to be reported as a liability and led management to identify a material weakness relating to complex equity transactions; that weakness was not remediated as of June 30, 2026.
What they said about what is next.
No quantitative revenue or EPS outlook is provided in the extracted Form 10-Q text.
The filing reads worse than the one before it.
What came before.
- 10-K · April 15, 2026
- Selectis Health (formerly Global Healthcare REIT) has been shifting toward an owner-operator model since 2019 and currently focuses on senior housing and post-acute/skilled nursing operations in the South/Southeast U.S.…
- 10-Q · August 14, 2025
- Selectis Health reported Q2 2025 revenue of $10,441,244, up versus Q2 2024 revenue of $9,584,802, driven by healthcare revenue growth. Operating loss narrowed and cash from operations turned positive year-to-date, but…
- 10-Q · May 21, 2025
- Selectis Health reported Q1 2025 revenue of $10,486,939 (up $994,533 or 10.48% vs Q1 2024's $9,492,406) and a smaller net loss of $655,969 (EPS -$0.22 vs -$0.34). Operating cash flow strengthened to $1,035,411 and free…
- 10-K · April 15, 2025
- Selectis Health (GBCS) continued its strategic shift from a landlord REIT to an owner-operator of senior housing and post-acute facilities, reporting that it owns 12 healthcare facilities and operates nine as of…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing GBCS makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever